Clik here to view.
Mawi iSWAB Microbiome-EL助力Prime Discoveries开发快速免提取的新冠病毒诊断检测
加利福尼亚州海沃德 (美国商业资讯)– 专注于生物采样创新技术开发的生物技术公司Mawi DNA Technologies(Mawi)宣布，Prime Discoveries已成功开发出用于检测SARS-CoV-2的等温扩增快速诊断检测技术CovidDetect™。该检测无需提取和纯化RNA，不到30分钟即可获得样本结果。该检测采用Mawi的新款iSWAB...
View ArticleClik here to view.
Lemonex Announces IND Approval for Phase 1 Clinical Trial of LEM-S401, siRNA...
SEOUL, South Korea Lemonex Inc., a biotechnology company pioneering messenger RNA (mRNA) and siRNA therapeutics based on novel nanoparticle drug delivery system announced on the 19th of April that...
View ArticleClik here to view.
Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the Supply...
View ArticleClik here to view.
ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Patients with...
TOKYO & BASKING RIDGE, N.J. Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD)...
View ArticleClik here to view.
Mawi iSWAB Microbiome-ELがプライム・ディスカバリーズによる抽出不要の迅速なCOVID診断アッセイの開発を実現
米カリフォルニア州ヘイワード （ビジネスワイヤ） —...
View ArticleClik here to view.
Global Phase 3 Trial of BeiGene’s PD-1 Inhibitor, Tislelizumab, in...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
遺伝子改変マウスモデルを提供する一流企業のジェムファーマテックが上海証券取引所に上場
米デラウェア州ウィルミントン （ビジネスワイヤ） — ジェムファーマテック（GemPharmatech LLC）は、2022年4月25日、親会社のGemPharmatech Co., Ltd.が上海証券取引所のスターマーケットに株式コード688046で上場したことをお知らせします。新規公開は普通株式5000万株を売り出し、公募価格は1株当り22.53円（3.51ドル）でした。...
View ArticleClik here to view.
Trial Master File Reference Model Group Officially Affiliates with CDISC
AUSTIN, Texas CDISC today announced an expansion of its offerings with the official affiliation of volunteer-based Trial Master File (TMF) Reference Model Group. The combined organizations will...
View ArticleClik here to view.
Asian Fund for Cancer Research Announces Chimera Bioengineering as the 2021...
HONG KONG Chimera Bioengineering has been selected as the winner of the Asian Fund for Cancer Research’s (AFCR) 2021 BRACE Award Venture Competition—a first-of-its-kind program for early stage...
View ArticleClik here to view.
武田荣获2022年国际制药工程协会年度设施奖两项大奖
日本大阪和马萨诸塞州剑桥市 (美国商业资讯)—武田(Takeda, TSE:4502/NYSE:TAK)今天宣布，国际制药工程协会(ISPE)在2022年度设施奖 (FOYA)的供应链和Pharma 4.0™类别中授予公司最高荣誉。在供应链类别中，武田凭借为异体间充质干细胞疗法实施以患者为中心的新供应链而获奖；武田位于德国辛根的疫苗生产设施则在Pharma 4.0类别中获奖。...
View ArticleClik here to view.
Clik here to view.
Genome Insight Draws $23 Million in Series B Funding to Open the Whole Genome...
SAN DIEGO Genome Insight, a global leader in Whole Genome Sequence analysis and interpretation, announced $23 million in Series B funding. Dunamu & Partners led the financing with participation...
View ArticleClik here to view.
NEXEL Earns the First ISO/IEC 17025:2017 Accreditation for iPSC-derived...
SEOUL, South Korea NEXEL, a global leader in induced pluripotent stem cell (iPSC) technology, announced today that it has achieved ISO/IEC 17025:2017 quality standard for laboratory testing, the...
View ArticleClik here to view.
Santen’s Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for...
EMERYVILLE, Calif. Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on eye care, today announced that Verkazia®...
View ArticleClik here to view.
知临集团提供有关其针对神经母细胞瘤的项目SACT-1的已完成1 期临床试验数据更新
纽约、伦敦和巴黎 临床阶段生物制药公司知临集团有限公司（纳斯达克代码：APM，巴黎泛欧证券交易所代码：APM）（「知临集团」或「知临」）欣然宣布 SACT-1 的 1期临床试验的最终数据。SACT-1是一种针对神经母细胞瘤和潜在其他癌症类型的重新利用的小分子药物。 继 2022 年 1 月宣布 SACT-1 的 1...
View ArticleClik here to view.
Propanc Biopharma Purchases Pharma Grade Raw Materials for PRP Manufacture in...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Clik here to view.
Alentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officer
BASEL, Switzerland Alentis Therapeutics (“Alentis” or “the Company”), the biotechnology company developing breakthrough treatments for organ fibrosis and fibrotic-associated cancers, today announced...
View ArticleClik here to view.
First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic...
SALT LAKE CITY Foldax®, Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical...
View ArticleClik here to view.
CANbridge-UMass Chan Medical School Gene Therapy Research to be Presented at...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc., (“CANbridge,”1228.HK) a leading China-based global biopharmaceutical company committed to the research, development and...
View Article